Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Vaccines

Free Subscription Articles published in Infect Immun Retrieve available abstracts of 21 articles: HTML format

Single Articles

October 2025
1. LATRE DE LATE P, Stoll IM, Ferm J, Madesh S, et al
   Rickettsia rickettsii inactivated whole cell antigen vaccine protects against Rocky Mountain spotted fever independent of the adjuvant used.
   Infect Immun. 2025 Oct 29:e0041225. doi: 10.1128/iai.00412.
   PubMed     Abstract available
   
   
   September 2025
2. LIU T, Zhao H, Wu Q, Wei Y, et al
   Evaluation of Mycoplasma mycoides subsp. mycoides antigens capable of stimulating host IRG-47 release identifies Mmm604, Mmm605, and Mmm606 as potential subunit vaccine antigens.
   Infect Immun. 2025 Sep 9:e0018625. doi: 10.1128/iai.00186.
   PubMed     Abstract available
   
   
   July 2025
3. BHIMANI S, Ferraro MJ
   Reply to Babich, "Using exosomes for universal vaccines".
   Infect Immun. 2025 Jul 9:e0020725. doi: 10.1128/iai.00207.
   PubMed    
   
   
   
4. BABICH AR
   Using exosomes for universal vaccines.
   Infect Immun. 2025 Jul 9:e0012925. doi: 10.1128/iai.00129.
   PubMed    
   
   
   May 2025
5. AZEVEDO JF, Joyner G, Kundu S, Samanta K, et al
   Maternal transfer of oral vaccine induced anti-OspA antibodies protects Peromyscus spp. from tick-transmitted Borrelia burgdorferi.
   Infect Immun. 2025 May 19:e0021625. doi: 10.1128/iai.00216.
   PubMed     Abstract available
   
   
   
6. VICKERS TJ, Buckley DP, Khatoon N, Sheikh A, et al
   Parenteral vaccination with recombinant EtpA glycoprotein impairs enterotoxigenic E. coli colonization.
   Infect Immun. 2025 May 1:e0060124. doi: 10.1128/iai.00601.
   PubMed     Abstract available
   
   
   April 2025
7. LI S, Upadhyay I, Seo H, Vakamalla SSR, et al
   Immunogenicity and preclinical efficacy characterization of ShecVax, a combined vaccine against Shigella and enterotoxigenic Escherichia coli.
   Infect Immun. 2025 Apr 10:e0000425. doi: 10.1128/iai.00004.
   PubMed     Abstract available
   
   
   March 2025
8. ZHANG C, Li S, Upadhyay I, Vakamalla SSR, et al
   Heterologous prime-boost immunization of two-component vaccine candidate PWDVax protected pigs against F18 enterotoxigenic Escherichia coli post-weaning diarrhea.
   Infect Immun. 2025 Mar 12:e0040624. doi: 10.1128/iai.00406.
   PubMed     Abstract available
   
   
   February 2025
9. PEREIRA IL, Hartwig DD
   Unveiling the role of adhesin proteins in controlling Acinetobacter baumannii infections: a systematic review.
   Infect Immun. 2025;93:e0034824.
   PubMed     Abstract available
   
   
   January 2025
10. 
    Expression of Concern for Teixeira et al., "Immunogenicity of a Prime-Boost Vaccine Containing the Circumsporozoite Proteins of Plasmodium vivax in Rodents".
    Infect Immun. 2025 Jan 13:e0054424. doi: 10.1128/iai.00544.
    PubMed    
    
    
    
11. EMERSON LE, Bhimani S, Rainey AL, Maurelli AT, et al
    Evaluating small extracellular vesicle-based vaccination across heterologous Salmonella strains isolated from wastewater.
    Infect Immun. 2025 Jan 13:e0048524. doi: 10.1128/iai.00485.
    PubMed     Abstract available
    
    
    December 2024
12. HALDAR R, Halder P, Koley H, Miyoshi S-i, et al
    A newly developed oral infection mouse model of shigellosis for immunogenicity and protective efficacy studies of a candidate vaccine.
    Infect Immun. 2024 Dec 18:e0034624. doi: 10.1128/iai.00346.
    PubMed     Abstract available
    
    
    November 2024
13. CHAMBERS GZ, Chambers KMF, Marconi RT
    A single immunization of Borreliella burgdorferi-infected mice with Vanguard crLyme elicits robust antibody responses to diverse strains and variants of outer surface protein C.
    Infect Immun. 2024;92:e0039624.
    PubMed     Abstract available
    
    
    October 2024
14. FRATZKE AP, Szule JA, Butler SM, Schaik EJv, et al
    Molecular mechanisms of Coxiella burnetii formalin-fixed cellular vaccine reactogenicity.
    Infect Immun. 2024 Oct 2:e0033524. doi: 10.1128/iai.00335.
    PubMed     Abstract available
    
    
    September 2024
15. CHORRO L, Ciolino T, Torres CL, Illenberger A, et al
    A cynomolgus monkey E. coli urinary tract infection model confirms efficacy of new FimH vaccine candidates.
    Infect Immun. 2024 Sep 19:e0016924. doi: 10.1128/iai.00169.
    PubMed     Abstract available
    
    
    August 2024
16. PYLES GM, Huckaby AB, Gutierrez MdlP, Witt WT, et al
    Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective against Bordetella pertussis respiratory infection in mice.
    Infect Immun. 2024;92:e0027024.
    PubMed     Abstract available
    
    
    July 2024
17. BITZER GJ, Fitzgerald NA, DeJong MA, Cunningham C, et al
    Immunization with an mRNA DTP vaccine protects against pertussis in rats.
    Infect Immun. 2024 Jul 17:e0052023. doi: 10.1128/iai.00520.
    PubMed     Abstract available
    
    
    June 2024
18. OSTAPCHUK YO, Lushova AV, Kan SA, Abdolla N, et al
    Long-term changes in the phenotype and cytokine production of monocytes in COVID-19 recovered and vaccinated individuals.
    Infect Immun. 2024 Jun 14:e0021624. doi: 10.1128/iai.00216.
    PubMed     Abstract available
    
    
    May 2024
19. IHARA S, Nguyen BV, Miyamoto Y, Eckmann L, et al
    Mucosal vaccination in a murine gnotobiotic model of Giardia lamblia infection.
    Infect Immun. 2024 May 9:e0006524. doi: 10.1128/iai.00065.
    PubMed     Abstract available
    
    
    April 2024
20. XING Y, Clark JR, Chang JD, Zulk JJ, et al
    Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach.
    Infect Immun. 2024 Apr 9:e0044023. doi: 10.1128/iai.00440.
    PubMed     Abstract available
    
    
    March 2024
21. VANCE DJ, Basir S, Piazza CL, Willsey GG, et al
    Single-domain antibodies reveal unique borrelicidal epitopes on the Lyme disease vaccine antigen, outer surface protein A (OspA).
    Infect Immun. 2024 Mar 12:e0008424. doi: 10.1128/iai.00084.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.